CombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016
27 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close...
CombiMatrix Notes Two Additional Blue Cross Blue Shield Health Plans Revise Medical Policies to Reimburse for Recurrent Pregnancy Loss Testing
26 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 26, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic...
CombiMatrix Provides Strategic Update
21 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Launches Preimplantation Genetic Diagnostic Testing for Single Gene Disorders and Chromosomal Translocations
05 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Comments on Medical Policy Revisions by Cigna Health and Three BCBS Health Plans to Reimburse for Recurrent Pregnancy Loss Testing
29 mars 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Closes $8.0 Million Underwritten Public Offering
24 mars 2016 09h59 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
ACOG and SMFM Update Practice Bulletins Recommending Prenatal Genetic Assessment for All Pregnant Women Regardless of Age or Other Risk Factors
23 mars 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 23, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Prices $8.0 Million Underwritten Public Offering
21 mars 2016 08h11 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at the ROTH Conference
09 mars 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Forms Scientific Advisory Board; Includes Leaders in Reproductive Health, Pathology, Genetics, Molecular Biology and Health Policy
26 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...